The comparison to IMCL is warranted, IMHO, and I have an interest in both companies. I have only been looking at them for a few months and currently only own BIOM. However, IMCL HAS been heavily in the news the last few weeks. After the spike to $18-ish, there were several articles regarding their products and the potential. It almost seemed to me that one article was linked to another. One analyst would say something and another would re-iterate the same lines. (MM and stock brokers need to sell something, right?) IMCL story has gotten around to a much greater extent that BIOM. I have been waiting for a pull back for IMCL to buy, but it has not happened, IMHO, because of the press coverage. They are also "about 2yrs" away from real revenues {could change with fast track). BIOM should see the same upward movement, but it will almost certainly retract again to lower (buying) levels.
Good comments, SM!
Jim |
